{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:10:32Z","timestamp":1767928232177,"version":"3.49.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:p>Several studies have suggested that inflammatory proteins may be associated with Coronavirus disease 2019 (COVID-19). However, the specific causal relationship between the 2 and whether blood metabolites act as mediators remains unclear. Therefore, the purpose of the present study is to investigate the causal relationship between inflammatory proteins and COVID-19 and to identify and quantify the role of blood metabolites as potential mediators. Two-sample Mendelian randomization (MR) and 2-step mediated MR analyses were used to investigate the causal relationships between 91 inflammatory proteins, 486 blood metabolites and COVID-19. A random-effects inverse variance weighted (IVW) approach was used as the primary analytical method, supplemented by weighted medians, MR-Egger and MR multivariate residual sums, and outliers to test MR hypotheses. Our results showed that 2 inflammatory proteins (interleukin-10 and interleukin-18) were positively associated with COVID-19 risk, while 1 inflammatory protein (PD-L1) was negatively associated. Further validation was performed using sensitivity analysis. The results of mediated MR showed that Betaine was a mediator of PD-L1 to COVID-19 with a mediation ratio of 15.92%. Our study suggests a genetic causality between specific inflammatory proteins and COVID-19, highlights the potential mediating role of the blood metabolite betaine, and contributes to a deeper understanding of the mechanism of action of severe COVID-19.<\/jats:p>","DOI":"10.1097\/md.0000000000041852","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:05:39Z","timestamp":1742310339000},"page":"e41852","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The effect of inflammatory proteins on COVID-19 is mediated by blood metabolites: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1889-230X","authenticated-orcid":false,"given":"Yuling","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Chen","sequence":"additional","affiliation":[{"name":"Medical Department, Nanchong Guoning Mental Health Hospital, Nanchong, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260108","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s11596-023-2797-3","article-title":"Clinical characteristics, diagnosis, and therapeutics of COVID-19: a review.","volume":"43","author":"Xie","year":"2023","journal-title":"Curr Med Sci"},{"key":"R2-20260108","doi-asserted-by":"crossref","first-page":"103086","DOI":"10.1016\/j.ijdrr.2022.103086","article-title":"Anxiety in patients treated in a temporary hospital in Belgrade, Serbia, during the first epidemic wave of COVID-19.","volume":"77","author":"Makevi\u0107","year":"2022","journal-title":"Int J Disaster Risk Reduction"},{"key":"R3-20260108","first-page":"m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ (Clinical research ed)"},{"key":"R4-20260108","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMe2001126","article-title":"Another decade, another coronavirus.","volume":"382","author":"Perlman","year":"2020","journal-title":"N Engl J Med"},{"key":"R5-20260108","doi-asserted-by":"crossref","first-page":"898192","DOI":"10.3389\/fimmu.2022.898192","article-title":"Role of COVID-19 vaccines in SARS-CoV-2 variants.","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"R6-20260108","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19.","volume":"375","author":"Merad","year":"2022","journal-title":"Science (New York, NY). Mar 11"},{"key":"R7-20260108","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 Pneumonia.","volume":"221","author":"Wang","year":"2020","journal-title":"J Infect Dis"},{"key":"R8-20260108","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"key":"R9-20260108","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","article-title":"Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.","volume":"70","author":"Yeoh","year":"2021","journal-title":"Gut"},{"key":"R10-20260108","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ (Clinical research ed)"},{"key":"R11-20260108","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R12-20260108","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1002\/cam4.6022","article-title":"Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: a Mendelian randomization study.","volume":"12","author":"Yun","year":"2023","journal-title":"Cancer medicine"},{"key":"R13-20260108","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R14-20260108","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors.","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"R15-20260108","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13167-023-00345-1","article-title":"The predictive, preventive, and personalized medicine of insomnia: gut microbiota and inflammation.","volume":"14","author":"Chen","year":"2023","journal-title":"EPMA J"},{"key":"R16-20260108","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R17-20260108","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/j.2040-4603.2019.tb00077.x","article-title":"Slc26 family of anion transporters in the gastrointestinal tract: expression, function, regulation, and role in disease.","volume":"9","author":"Seidler","year":"2019","journal-title":"Comprehensive Physiol"},{"key":"R18-20260108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000504417","article-title":"The handling of oxalate in the body and the origin of oxalate in calcium oxalate stones.","volume":"104","author":"Huang","year":"2020","journal-title":"Urol Int"},{"key":"R19-20260108","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3390\/nu11102314","article-title":"Health-promoting properties of selected cyclitols for metabolic syndrome and diabetes.","volume":"11","author":"Antonowski","year":"2019","journal-title":"Nutrients"},{"key":"R20-20260108","doi-asserted-by":"crossref","first-page":"e829","DOI":"10.1016\/S2665-9913(21)00321-0","article-title":"IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19.","volume":"3","author":"Della-Torre","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"R21-20260108","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.23812\/20-1-E","article-title":"Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"R22-20260108","doi-asserted-by":"crossref","first-page":"941422","DOI":"10.3389\/fmed.2022.941422","article-title":"Impaired tryptophan metabolism in the gastrointestinal tract of patients with critical coronavirus disease 2019.","volume":"9","author":"Yokoyama","year":"2022","journal-title":"Front Med"},{"key":"R23-20260108","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.gastro.2021.10.013","article-title":"Prolonged impairment of short-chain fatty acid and L-Isoleucine biosynthesis in gut microbiome in patients with COVID-19.","volume":"162","author":"Zhang","year":"2022","journal-title":"Gastroenterology"},{"key":"R24-20260108","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"R25-20260108","doi-asserted-by":"crossref","first-page":"338267","DOI":"10.1016\/j.aca.2021.338267","article-title":"The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes.","volume":"1152","author":"Lv","year":"2021","journal-title":"Anal Chim Acta"},{"key":"R26-20260108","doi-asserted-by":"crossref","first-page":"103750","DOI":"10.1016\/j.jri.2022.103750","article-title":"IL-10: A bridge between immune cells and metabolism during pregnancy.","volume":"154","author":"Wang","year":"2022","journal-title":"J Reprod Immunol"},{"key":"R27-20260108","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/17534259231172079","article-title":"Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients.","volume":"29","author":"Mirja\u010di\u0107 Martinovi\u0107","year":"2023","journal-title":"Innate Immun"},{"key":"R28-20260108","first-page":"1178","article-title":"Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 Severity.","volume":"6","author":"Tang","year":"2020","journal-title":"Engineering (Beijing, China)"},{"key":"R29-20260108","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1172\/jci.insight.139834","article-title":"Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.","volume":"5","author":"Zhao","year":"2020","journal-title":"JCI insight"},{"key":"R31-20260108","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease.","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R32-20260108","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology.","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"key":"R33-20260108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19.","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"R34-20260108","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/jcp.30008","article-title":"IL-18 and infections: is there a role for targeted therapies?","volume":"236","author":"Vecchi\u00e9","year":"2021","journal-title":"J Cell Physiol"},{"key":"R35-20260108","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-81-2-247","article-title":"The gamma-glutamyl cycle. Diseases associated with specific enzyme deficiencies.","volume":"81","author":"Meister","year":"1974","journal-title":"Ann Intern Med"},{"key":"R36-20260108","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2011.01.031","article-title":"Serum metabolomics reveals \u03b3-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.","volume":"55","author":"Soga","year":"2011","journal-title":"J Hepatol"},{"key":"R37-20260108","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40164-018-0105-x","article-title":"Understanding metabolic changes in aging bone marrow.","volume":"7","author":"Connor","year":"2018","journal-title":"Exp Hematol Oncol"},{"key":"R38-20260108","doi-asserted-by":"crossref","first-page":"E6274","DOI":"10.1073\/pnas.1710849115","article-title":"Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma.","volume":"115","author":"Priolo","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"R39-20260108","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/ijc.32218","article-title":"Prospective serum metabolomic profiling of lethal prostate cancer.","volume":"145","author":"Huang","year":"2019","journal-title":"Int J Cancer"},{"key":"R40-20260108","doi-asserted-by":"crossref","first-page":"22543","DOI":"10.1038\/s41598-023-49233-8","article-title":"Genetically predicted 486 blood metabolites concerning risk of systemic lupus erythematosus: a Mendelian randomization study.","volume":"13","author":"Zhao","year":"2023","journal-title":"Sci Rep"},{"key":"R41-20260108","doi-asserted-by":"crossref","first-page":"676980","DOI":"10.3389\/fimmu.2021.676980","article-title":"Integrative multi-omics reveals serum markers of tuberculosis in advanced HIV.","volume":"12","author":"Krishnan","year":"2021","journal-title":"Front Immunol"},{"key":"R42-20260108","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fcimb.2019.00207","article-title":"The PD-1\/PD-L1 axis and virus infections: a delicate balance.","volume":"9","author":"Sch\u00f6nrich","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"R43-20260108","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation.","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat Immunol"},{"key":"R44-20260108","doi-asserted-by":"crossref","first-page":"695242","DOI":"10.3389\/fimmu.2021.695242","article-title":"PD-L1 dysregulation in COVID-19 patients.","volume":"12","author":"Sabbatino","year":"2021","journal-title":"Front Immunol"},{"key":"R45-20260108","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with Coronavirus disease 2019 (COVID-19).","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"R46-20260108","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2217\/fmb-2022-0103","article-title":"Role of the PD-1 and PD-L1 axis in COVID-19.","volume":"17","author":"Bonam","year":"2022","journal-title":"Future Microbiol"},{"key":"R47-20260108","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.","volume":"198","author":"Ansari","year":"2003","journal-title":"J Exp Med"},{"key":"R48-20260108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00210-022-02210-w","article-title":"Vitamin D can reduce severity in COVID-19 through regulation of PD-L1.","volume":"395","author":"Aygun","year":"2022","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R49-20260108","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.3390\/jcm12216812","article-title":"Different prognostic role of soluble PD-L1 in the course of severe and non-severe COVID-19.","volume":"12","author":"Sabbatino","year":"2023","journal-title":"J Clin Med"},{"key":"R50-20260108","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fimmu.2018.01070","article-title":"Betaine in inflammation: mechanistic aspects and applications.","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:00:49Z","timestamp":1767906049000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041852","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}